$9.59
Oric Pharmaceuticals Inc is a biotechnology business based in the US. Oric Pharmaceuticals Inc shares (ORIC) are listed on the NASDAQ and all prices are listed in US Dollars. Oric Pharmaceuticals Inc employs 107 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Oric Pharmaceuticals Inc stock
How to buy Oric Pharmaceuticals Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ORIC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Oric Pharmaceuticals Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Oric Pharmaceuticals Inc stock price (NASDAQ: ORIC)
Use our graph to track the performance of ORIC stocks over time.Oric Pharmaceuticals Inc shares at a glance
Latest market close | $10.07 |
---|---|
52-week range | $5.27 - $16.65 |
50-day moving average | $9.42 |
200-day moving average | $9.91 |
Wall St. target price | $18.57 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.76 |
Is it a good time to buy Oric Pharmaceuticals Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Oric Pharmaceuticals Inc price performance over time
Historical closes compared with the close of $10.07 from 2024-09-03
1 week (2024-08-29) | -1.27% |
---|---|
1 month (2024-08-05) | 13.53% |
3 months (2024-06-05) | 9.81% |
6 months (2024-03-05) | -34.99% |
1 year (2023-09-05) | 11.89% |
---|---|
2 years (2022-09-02) | 186.89% |
3 years (2021-09-03) | 23 |
5 years (2019-09-01) | N/A |
Oric Pharmaceuticals Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -25.2% |
Return on equity TTM | -38.79% |
Profit margin | 0% |
Book value | $4.47 |
Market Capitalization | $731.5 million |
TTM: trailing 12 months
Oric Pharmaceuticals Inc share dividends
We're not expecting Oric Pharmaceuticals Inc to pay a dividend over the next 12 months.
Oric Pharmaceuticals Inc share price volatility
Over the last 12 months, Oric Pharmaceuticals Inc's shares have ranged in value from as little as $5.27 up to $16.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oric Pharmaceuticals Inc's is 1.117. This would suggest that Oric Pharmaceuticals Inc's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Oric Pharmaceuticals Inc overview
ORIC Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc. ; a license agreement with Mirati Therapeutics, Inc. ; and clinical development collaboration agreement with Pfizer Inc.
Frequently asked questions
What percentage of Oric Pharmaceuticals Inc is owned by insiders or institutions?Currently 9.131% of Oric Pharmaceuticals Inc shares are held by insiders and 97.029% by institutions. How many people work for Oric Pharmaceuticals Inc?
Latest data suggests 107 work at Oric Pharmaceuticals Inc. When does the fiscal year end for Oric Pharmaceuticals Inc?
Oric Pharmaceuticals Inc's fiscal year ends in December. Where is Oric Pharmaceuticals Inc based?
Oric Pharmaceuticals Inc's address is: 240 East Grand Avenue, South San Francisco, CA, United States, 94080 What is Oric Pharmaceuticals Inc's ISIN number?
Oric Pharmaceuticals Inc's international securities identification number is: US68622P1093 What is Oric Pharmaceuticals Inc's CUSIP number?
Oric Pharmaceuticals Inc's Committee on Uniform Securities Identification Procedures number is: 68622P109
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question